Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study

Hum Gene Ther. 1995 Feb;6(2):195-204. doi: 10.1089/hum.1995.6.2-195.

Authors

R E Sobol¹, I Royston, H Fakhrai, D L Shawler, C Carson, O Dorigo, R Gjerset, D P Gold, J Koziol, D Mercola, et al.

Affiliation

¹ San Diego Regional Cancer Center, CA 92121, USA.

PMID: 7734519
DOI: 10.1089/hum.1995.6.2-195

No abstract available

MeSH terms

Cell Transplantation
Clinical Protocols
Clinical Trials, Phase I as Topic*
Colonic Neoplasms / therapy*
Fibroblasts
Gene Transfer Techniques* / adverse effects
Genetic Therapy / methods*
Humans
Informed Consent
Interleukin-2 / genetics*
Interleukin-2 / therapeutic use

Substances

Interleukin-2